December 2, 2020 | BCAN is pleased to announce two 2021 Bladder Cancer Research Innovation Awards to support the work of investigators with exceptionally novel and creative projects with great potential to produce breakthroughs in our understanding of the management of bladder cancer. Two proposals will be funded for $300,000
There is no excerpt because this is a protected post.
$300,000 Award Fuels Bladder Cancer Research Innovation FOR IMMEDIATE RELEASE: (June 22, 2020: Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced the recipient of its prestigious Bladder Cancer Research Innovation Award. This year’s awardee is Jeffrey Ravetch, MD, PhD, Professor and Head of the Laboratory of Molecular Genetics
Co-sponsored by the: U.S. Food and Drug Administration (FDA) and the Bladder Cancer Advocacy Network (BCAN) Date: Thursday, August 8, 2019 from Noon-4PM EST Location: Capital Hilton, 1001 16th Street NW, Washington, DC 20036 Cost: Free – WebEx Only Neoadjuvant cisplatin-based combination chemotherapy followed by radical cystectomy is a standard
The 2018 BCAN Young Investigator Award will support the research of Philip Abbosh, MD, PhD, Assistant Professor, at Fox Chase Cancer Center, for his work on “Next-generation sequencing to enhance initial staging and dynamically monitor disease response in upper tract urothelial carcinoma (UTUC).” Dr. Abbosh will evaluate the performance of